Executive Group F2F meeting

The Union World Conference served as a good occasion several PanACEA get togethers. On the 25th of October the Executive Group came together to discuss the completion of the HR1 trial and the preparations for the upcoming trials.

The TBA was also invited to prepare for the SimpliciTB trial for which EDCTP favourably evaluated a grant application by PanACEA and the TB Alliance. SimpliciTB is a global phase III trial to evaluate the efficacy, safety and tolerability of a novel and potentially shorter drug regimen of Bedaquiline, Pretomanid, Moxifloxacin and Pyrazinamide (BPaMZ).